| 6/21/2010 | HYLM | Valeant to refinance 7 5/8%, 8 3/8% notes as part of Biovail merger
|
| 9/23/2008 | BKHY | S&P drops Biovail
|
| 12/11/2007 | BKHY | S&P: Biovail unchanged
|
| 12/6/2007 | BKHY | S&P lowers Biovail
|
| 2/28/2007 | HY | Biovail calls 7 7/8% notes due 2010
|
| 12/6/2006 | HY | Biovail plans redemption of all 7 7/8% notes due 2010
|
| 11/17/2006 | BKCVHY | Moody's ups Biovail view to stable
|
| 9/21/2006 | BKBTCVHY | Moody's revises ratings for nine U.S. pharma companies
|
| 8/2/2006 | BKBTCVHY | S&P: Biovail unchanged
|
| 5/25/2006 | BTHY | Biovail tenders for $56.6 million of 7 7/8% notes
|
| 12/1/2005 | BKHY | Moody's affirms Biovail
|
| 11/15/2005 | BKBTHY | S&P: Biovail unaffected
|
| 8/26/2005 | BKBTHY | S&P ups Biovail view to stable, rates loan BBB-
|
| 3/7/2005 | BKHY | S&P: Biovail unaffected
|
| 6/16/2004 | BKHY | Moody's confirms Biovail ratings
|
| 3/9/2004 | BKHY | S&P: Biovail outlook negative
|
| 3/9/2004 | HY | Market Commentary: MGM Mirage, Corning, Amkor lead busy primary; Biovail off as agencies eye downgrade
|
| 3/8/2004 | BKHY | Moody's may cut Biovail rating
|
| 12/23/2003 | HY | Market Commentary: Parmalat retreats further as woes grow; Rhodia up on debt deal; primary stilled
|
| 12/10/2003 | HY | Market Commentary: Blue Ridge deal, downsized THL/Simmons price; Collins & Aikman speeds upward
|
| 11/21/2003 | HY | Market Commentary: J. Ray McDermott sells 10-years; Hyundai shelved; Sbarro fall continues
|
| 11/6/2003 | HY | S&P cuts Biovail outlook
|
| 10/30/2003 | HY | Market Commentary: Silgan, O'Charley's price deals; Elan, Levi firmer, Biovail off on earnings; funds essentially flat
|
| 5/2/2002 | HY | Moody's downgrades Sealy Mattress' debt ratings
|
| 3/27/2002 | HY | Market Commentary: Adelphia falls but reaction muted; upsized Boyd Gaming trades higher in secondary
|
| 3/27/2002 | HY | UBS says Biovail 8% yield is lowest ever for B2 health care credit
|
| 3/26/2002 | HY | Moody's puts Pennzoil-Quaker State on upgrade review
|
| 3/26/2002 | HY | Pennzoil debt firmer on Shell acquisition bid; Crown Cork holds gains; Hockey Co. scores
|
| 3/25/2002 | HY | Market Commentary: Crown Cork boosted by buyout buzz; Calpine shrugs off S&P downgrade; upsized Biovail prices
|
| 3/25/2002 | HY | New Issue: Biovail eight-year notes upsized to $400 million, yield 8%
|
| 3/25/2002 | HY | S&P downgrades Calpine
|
| 3/22/2002 | HY | Biovail $275 million eight-year notes talk at 8%-81/4%, pricing Monday
|
| 3/19/2002 | HY | Biovail starts roadshow for $275 million eight-year notes Wednesday; via UBS Warburg
|
| 3/19/2002 | HY | Market Commentary: XM Satellite Radio runs into static; Calpine powers up; Hovnanian brings new deal
|
